Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (31-40 of 775) with videos related to

Pageof 78
Sort By:
Seminars in Liver Disease|November 14, 2013
Bile acid-mediated control of liver triglyceridesClaudia Fuchs, Thierry Claudel, Michael Trauner
Nature Clinical Practice. Gastroenterology & Hepatology|September 30, 2006
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsisAndreas Geier, Peter Fickert, Michael Trauner
Gastroenterology|March 7, 2013
Bile acids as modulators of gut microbiota linking dietary habits and inflammatory bowel disease: a potentially dangerous liaisonMichael Trauner, Peter Fickert, Herbert Tilg
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver DiseasesEmina Halilbasic, Daniel Steinacher, Michael Trauner
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver DiseaseDaniel Steinacher, Thierry Claudel, Michael Trauner
Seminars in Liver Disease|February 14, 2007
MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromesMichael Trauner, Peter Fickert, Martin Wagner
Journal of Hepatology|July 15, 2009
New molecular insights into the mechanisms of cholestasisMartin Wagner, Gernot Zollner, Michael Trauner
Pharmacology & Therapeutics|April 15, 2010
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicityGernot Zollner, Martin Wagner, Michael Trauner
Alimentary Pharmacology & Therapeutics|September 23, 2021
Review article: therapeutic aspects of bile acid signalling in the gut-liver axisBenedikt Simbrunner, Michael Trauner, Thomas Reiberger
Hepatology (Baltimore, Md.)|April 10, 2023
Reply: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Thomas Reiberger, Michael Trauner
Pageof 78

Showing results (31-40 of 775) with videos related to

Sort By:
Pageof 78
Seminars in Liver Disease|November 14, 2013
Bile acid-mediated control of liver triglyceridesClaudia Fuchs, Thierry Claudel, Michael Trauner
Nature Clinical Practice. Gastroenterology & Hepatology|September 30, 2006
Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsisAndreas Geier, Peter Fickert, Michael Trauner
Gastroenterology|March 7, 2013
Bile acids as modulators of gut microbiota linking dietary habits and inflammatory bowel disease: a potentially dangerous liaisonMichael Trauner, Peter Fickert, Herbert Tilg
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver DiseasesEmina Halilbasic, Daniel Steinacher, Michael Trauner
Digestive Diseases (Basel, Switzerland)|March 2, 2017
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver DiseaseDaniel Steinacher, Thierry Claudel, Michael Trauner
Seminars in Liver Disease|February 14, 2007
MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromesMichael Trauner, Peter Fickert, Martin Wagner
Journal of Hepatology|July 15, 2009
New molecular insights into the mechanisms of cholestasisMartin Wagner, Gernot Zollner, Michael Trauner
Pharmacology & Therapeutics|April 15, 2010
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicityGernot Zollner, Martin Wagner, Michael Trauner
Alimentary Pharmacology & Therapeutics|September 23, 2021
Review article: therapeutic aspects of bile acid signalling in the gut-liver axisBenedikt Simbrunner, Michael Trauner, Thomas Reiberger
Hepatology (Baltimore, Md.)|April 10, 2023
Reply: Progressive cholestasis and associated sclerosing cholangitis are complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Thomas Reiberger, Michael Trauner
Pageof 78